Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:22
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Low-income tenants lack options as old mobile home parks are razed
Birkenstock shares extend rally, hit IPO price for first time
US banks have strengthened liquidity after spring turmoil but must remain vigilant -regulator
California paves way for more insurance coverage in disaster-prone areas
National Coffee Day deals: Free drinks at Dunkin', Krispy Kreme and more
DeVry University Advantage Academy Ranks in Top 10 of Chicago Parent’s Best Public High Schools List
Apple's iPhone 14 users get another year of free satellite SOS access
Irish budget helps lift consumer sentiment from six-month low - survey